Experience with dipivalyl epinephrine. Its effectiveness, alone or in combination, and its side effects.

Author: CebonL, GilliesW E, WestR H

Paper Details 
Original Abstract of the Article :
Dipivalyl epinephrine was as effective as adrenaline as an eyedrop for glaucoma. It was responsible for fewer side effects, through side effects did occur. It had an additive effect when used with timolol maleate and, in 12 of 14 patients on long-term medication with both drugs, a rise of pressure o...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1442-9071.1983.tb01071.x

データ提供:米国国立医学図書館(NLM)

Dipivalyl Epinephrine for Glaucoma Treatment

Glaucoma is a serious eye condition that requires effective treatment to preserve vision. This study examines the efficacy and safety of dipivalyl epinephrine as a treatment for glaucoma. The researchers conducted a series of studies to evaluate dipivalyl epinephrine's effectiveness as a standalone therapy and in combination with other glaucoma medications.

Dipivalyl Epinephrine: A Potential Treatment Option for Glaucoma

The study found that dipivalyl epinephrine was as effective as adrenaline in reducing intraocular pressure (IOP), a key factor in managing glaucoma. Moreover, dipivalyl epinephrine was associated with fewer side effects compared to adrenaline.

Importance of Evaluating New Treatment Options

This study highlights the importance of continuously evaluating new treatment options for glaucoma. The researchers' findings suggest that dipivalyl epinephrine could offer a valuable alternative to existing therapies, potentially improving patient outcomes and minimizing side effects.

Dr. Camel's Conclusion

This research is like a refreshing spring in the desert, offering a potential solution to the challenges of glaucoma treatment. The study's findings provide compelling evidence for the efficacy and safety of dipivalyl epinephrine, opening new avenues for improving patient care and potentially preserving vision.

Date :
  1. Date Completed 1983-12-17
  2. Date Revised 2019-10-31
Further Info :

Pubmed ID

6639507

DOI: Digital Object Identifier

10.1111/j.1442-9071.1983.tb01071.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.